Biomarkers of inflammation, such as TNF-α, interleukin (IL)-6, monocyte chemoattractant protein-1 (MCP-1, CCL2), and C-reactive protein, are increased in obesity, associated with insulin resistance, and predict the development of type 2 diabetes [13]–[16]. Here, CCL2 is linked to type 2 diabetes mellitus.